FDA applicant
Augmenix, Inc.
FDA records 5 decisions for Augmenix, Inc. (Waltham, MA) from 2013 to 2019: 4 510(k) clearances and 1 De Novo grant. Most are in product codes OVB (Hydrogel Spacer) and NEU (Marker, Radiographic, Implantable). Its devices cite 5 predicates, 3 of them its own earlier devices. 2 recalls are linked to its devices.
Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) refreshed weekly
How often FDA has decided Augmenix, Inc.’s devices, and how often a recall has named them.
FDA decisions per year
1in 2019
2026 so far, outlined.
Recalls per year
2in 2022
Class I Class II/III not classified
Planning a device like Augmenix, Inc.’s? A 510(k) Report ranks candidate predicates for your device by lineage, citations and recall history, with the review-time outlook.
See the 510(k) Report